Marubbi D - Search Results

1

Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.

Baronchelli S, Bentivegna A, Redaelli S, Riva G, Butta V, Paoletta L, Isimbaldi G, Miozzo M, Tabano S, Daga A, Marubbi D, Cattaneo M, Biunno I, Dalprà L. Baronchelli S, et al. Among authors: marubbi d. PLoS One. 2013;8(2):e57462. doi: 10.1371/journal.pone.0057462. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23468990 Free PMC article.

2

Glioma immunotherapy by IL-21 gene-modified cells or by recombinant IL-21 involves antibody responses.

Daga A, Orengo AM, Gangemi RM, Marubbi D, Perera M, Comes A, Ferrini S, Corte G. Daga A, et al. Among authors: marubbi d. Int J Cancer. 2007 Oct 15;121(8):1756-63. doi: 10.1002/ijc.22901. Int J Cancer. 2007. PMID: 17582604 Free article.

3

Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors.

Griffero F, Daga A, Marubbi D, Capra MC, Melotti A, Pattarozzi A, Gatti M, Bajetto A, Porcile C, Barbieri F, Favoni RE, Lo Casto M, Zona G, Spaziante R, Florio T, Corte G. Griffero F, et al. Among authors: marubbi d. J Biol Chem. 2009 Mar 13;284(11):7138-48. doi: 10.1074/jbc.M807111200. Epub 2009 Jan 14. J Biol Chem. 2009. PMID: 19147502 Free PMC article.

4

Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.

Carra E, Barbieri F, Marubbi D, Pattarozzi A, Favoni RE, Florio T, Daga A. Carra E, et al. Among authors: marubbi d. Cell Cycle. 2013 Feb 1;12(3):491-500. doi: 10.4161/cc.23372. Epub 2013 Jan 16. Cell Cycle. 2013. PMID: 23324350 Free PMC article.

5

In vitro and in vivo characterization of highly purified human mesothelioma derived cells.

Melotti A, Daga A, Marubbi D, Zunino A, Mutti L, Corte G. Melotti A, et al. Among authors: marubbi d. BMC Cancer. 2010 Feb 22;10:54. doi: 10.1186/1471-2407-10-54. BMC Cancer. 2010. PMID: 20175889 Free PMC article.

6

Radiosensitization of orthotopic GIC-driven glioblastoma by doxycycline causes skin damage.

Frosina G, Marubbi D, Marcello D, Daga A. Frosina G, et al. Among authors: marubbi d. Radiat Oncol. 2019 Apr 8;14(1):58. doi: 10.1186/s13014-019-1266-4. Radiat Oncol. 2019. PMID: 30961616 Free PMC article.

7

SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G. Gangemi RM, et al. Among authors: marubbi d. Stem Cells. 2009 Jan;27(1):40-8. doi: 10.1634/stemcells.2008-0493. Stem Cells. 2009. PMID: 18948646

8

Effects of Emx2 inactivation on the gene expression profile of neural precursors.

Gangemi RM, Daga A, Muzio L, Marubbi D, Cocozza S, Perera M, Verardo S, Bordo D, Griffero F, Capra MC, Mallamaci A, Corte G. Gangemi RM, et al. Among authors: marubbi d. Eur J Neurosci. 2006 Jan;23(2):325-34. doi: 10.1111/j.1460-9568.2005.04559.x. Eur J Neurosci. 2006. PMID: 16420441

9

NK cells recognize and kill human glioblastoma cells with stem cell-like properties.

Castriconi R, Daga A, Dondero A, Zona G, Poliani PL, Melotti A, Griffero F, Marubbi D, Spaziante R, Bellora F, Moretta L, Moretta A, Corte G, Bottino C. Castriconi R, et al. Among authors: marubbi d. J Immunol. 2009 Mar 15;182(6):3530-9. doi: 10.4049/jimmunol.0802845. J Immunol. 2009. PMID: 19265131

10

The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models.

Frosina G, Marubbi D, Marcello D, Vecchio D, Daga A. Frosina G, et al. Among authors: marubbi d. Crit Rev Oncol Hematol. 2019 Jun;138:214-222. doi: 10.1016/j.critrevonc.2019.04.015. Epub 2019 Apr 21. Crit Rev Oncol Hematol. 2019. PMID: 31092378 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page